Analysts are seeing that companies and investors are significantly benefiting from the integration of artificial intelligence (AI) across various sectors.

The use of artificial intelligence is increasingly enhancing efficiency, reducing costs and driving innovation.

In some sectors, AI-powered automation streamlines operations and improves customer experiences through personalized recommendations. This leads to increased sales and customer satisfaction.

Investors are seeing substantial returns from companies that effectively integrate AI. Statistics show that companies tend to outperform their peers by leveraging data-driven insights for better decision-making and strategic planning.

Stockhouse recently continued its series of interviews with Austin Zelan, founder of Zelan Consulting and Setter AI.

Watch the full interview in the video above to hear the discussion about how companies are fully integrating the use of AI. It also covers what investors should be looking at to shape their investment strategies with companies using artificial intelligence.

To see more from our AI series with Austin Zelan, head to the rise of autonomous trading systems. As well, check out Enterprises using AI to improve production comes with its challenges.

To stay up to date on all the latest AI and stock market news, head to Stockhouse.com.

Join the discussion: Check out what everyone is saying about artificial intelligence stocks over on Stockhouse’s stock forums and message boards.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.


More From The Market Online
Lightspeed Introduces the Next Generation Kitchen Display System (CNW Group Lightspeed Commerce Inc.

Buzz on the Bullboards: Bombardier, world woes, a smart fridge, and top shelf weed

A highlight of the week was Bombardier (TSX:BBD), which reported impressive growth in its Q3 2024 results.
image of scientist looking into a microscope

BriaCell begins phase 1/2 trial of Bria-OTS™ for breast cancer

BriaCell Therapeutics (TSX:BCT) initiates a Phase 1/2 clinical trial of Bria-OTS for metastatic breast cancer.

West Red Lake Gold reports high-grade results at Upper 8

West Red Lake Gold (TSXV:WRLG) reports high grade results from its Uper 8 Target at the Madsen Property in Ontario.